We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from other web pages that is not governed by us.
Refresher - CHEP+ 2026: Mr. Gefry Case Study of screening for diabetic Nephropathy
Refresher - CHEP+ 2026: Mr. Gefry Case Study of screening for diabetic Nephropathy
1. Describe annual kidney disease screening recommendations
2. Describe the prevalence of low eGFR and abnormal urine ACR
3. Outline the rationale for annual screening including the personal and public health benefits and cost effectiveness
4. Integrate new Diabetes Canada screening recommendations into routine practice